MEOX1 and ovarian cancer: Recently, overexpression of mesenchyme homeobox 1 (MEOX1), a transcriptional factor controlling somite development, has been found to be involved in the occurrence and progression of ovarian cancer by regulating proliferation and EMT of cancer cells, lymphangiogenesis, and ECM remodeling [111].